Cargando…

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?

SIMPLE SUMMARY: V domain immunoglobulin suppressor of T cell activation (VISTA) has recently been described as a protein expressed on immune cells and tumour cells and a possible target for immunotherapy. We show for the first time that VISTA is broadly expressed across subtypes of soft tissue sarco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albertsmeier, Markus, Altendorf-Hofmann, Annelore, Lindner, Lars H., Issels, Rolf D., Kampmann, Eric, Dürr, Hans-Roland, Angele, Martin K., Klauschen, Frederick, Werner, Jens, Jungbluth, Achim A., Knösel, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870227/ https://www.ncbi.nlm.nih.gov/pubmed/35205752 http://dx.doi.org/10.3390/cancers14041006

Ejemplares similares

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
por: Albertsmeier, Markus, et al.
Publicado: (2020)

TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
por: Berclaz, Luc M., et al.
Publicado: (2023)

Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy
por: Berclaz, Luc M., et al.
Publicado: (2021)

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma
por: Bücklein, Veit, et al.
Publicado: (2020)

Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms
por: Bösch, Florian, et al.
Publicado: (2022)

A novel immune-related gene signature predicting survival in sarcoma patients
por: Ren, Haoyu, et al.
Publicado: (2021)

Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor
por: Bösch, Florian, et al.
Publicado: (2020)

The Effect of Resection Margin on Local Recurrence and Survival in High Grade Soft Tissue Sarcoma of the Extremities: How Far Is Far Enough?
por: Bilgeri, Annika, et al.
Publicado: (2020)

Amputation for Extremity Sarcoma: Indications and Outcomes
por: Kirilova, Maya, et al.
Publicado: (2021)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients
por: Bücklein, Veit, et al.
Publicado: (2016)

Immunotherapy for Bone and Soft Tissue Sarcomas
por: Uehara, Takenori, et al.
Publicado: (2015)

Terminating Cancer by Blocking VISTA as a Novel Immunotherapy: Hasta la vista, baby
por: Yum, Ji-Eun Irene, et al.
Publicado: (2021)

Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas
por: Klein, Alexander, et al.
Publicado: (2021)

Sarcomas of the extremities and the pelvis: comparing local recurrence after incisional and after core-needle biopsy
por: Klein, Alexander, et al.
Publicado: (2022)

VISTA: A Promising Target for Cancer Immunotherapy?
por: Tagliamento, Marco, et al.
Publicado: (2021)

Implementing precision oncology for sarcoma patients: the CCC(LMU)molecular tumor board experience
por: Berclaz, Luc M., et al.
Publicado: (2023)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy
por: Hong, Shanjuan, et al.
Publicado: (2019)

Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery
por: Laurentius, Thea, et al.
Publicado: (2010)

Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
por: Bauschke, Astrid, et al.
Publicado: (2022)

New emerging targets in cancer immunotherapy: the role of VISTA
por: Tagliamento, Marco, et al.
Publicado: (2020)

Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis
por: Bauschke, Astrid, et al.
Publicado: (2020)

Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy
por: Raj, Shailaja, et al.
Publicado: (2018)

Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma
por: Chan, Abigail S, et al.
Publicado: (2020)

Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas
por: Kerrison, William G. J., et al.
Publicado: (2022)

Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness
por: Panagi, Myrofora, et al.
Publicado: (2022)

Chirurgische Therapie von Leber- und Pankreasmetastasen von Nierenzellkarzinomen
por: Bauschke, Astrid, et al.
Publicado: (2021)

FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors
por: Briest, Franziska, et al.
Publicado: (2015)

Ten recommendations for sarcoma surgery: consensus of the surgical societies based on the German S3 guideline “Adult Soft Tissue Sarcomas”
por: Jakob, Jens, et al.
Publicado: (2023)

Impact of postoperative baseline MRI on diagnostic confidence and performance in detecting local recurrence of soft-tissue sarcoma of the limb
por: Goller, Sophia Samira, et al.
Publicado: (2023)

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
por: Monga, Varun, et al.
Publicado: (2020)

Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy
por: Sousa, Luana Madalena, et al.
Publicado: (2021)

The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy
por: Fortes-Andrade, Tânia, et al.
Publicado: (2021)

VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy
por: Yuan, Long, et al.
Publicado: (2021)

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
por: Shekari, Najibeh, et al.
Publicado: (2023)

Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients
por: Neuberger, Michael, et al.
Publicado: (2022)

Surgical treatment of liver metastases from non-colorectal non-neuroendocrine carcinomas
por: Bauschke, Astrid, et al.
Publicado: (2021)

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
por: Fazel, Mina, et al.
Publicado: (2023)

The Landscape of Immunotherapy for Retroperitoneal Sarcoma
por: Gingrich, Alicia A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bml2bgal5igr8a4bnigkrhhcrv